Filing and business context
This is Vector Acquisition Corporation’s unaudited Form 10-Q for the quarter ended March 31, 2021—not an operating-company 10-Q filed by Rocket Lab Corp. Vector was a SPAC with no operating revenue or operations; its activity related to formation, its IPO, and pursuing a business combination. Rocket Lab USA, Inc. was the proposed merger target.
Financial results and position
| Metric | Q1 2021 / March 31, 2021 |
|---|---|
| Revenue | None; the filing says Vector expected no operating revenue before a business combination. |
| Formation and operating costs | $1.93 million |
| Net loss | $23.56 million, including a $21.63 million noncash loss from the increase in warrant liabilities; trust interest income was $4,810. |
| Cash from operations | $440,450 used; ending cash outside the trust was $425,453. |
| Trust assets | $320.01 million, primarily invested in U.S. Treasury securities or qualifying money market funds. |
| Total liabilities | $59.09 million, including $46.20 million of warrant liabilities and an $11.20 million deferred underwriting fee payable if a business combination closes. |
| Debt and liquidity | No outstanding working-capital loans or long-term debt reported. Management said Vector lacked sufficient liquidity to meet anticipated obligations over the next year from its own resources, but expected Sponsor funding to cover working-capital needs. |
Compared with December 31, 2020, cash declined from $865,903 to $425,453; trust assets were nearly unchanged. Warrant liabilities rose from $24.56 million to $46.20 million, driving most of the quarter’s reported loss. The filing does not provide a comparable Q1 2020 income statement.
Transaction, outlook, and key risks
- Vector entered into a merger agreement with Rocket Lab on March 1, 2021, amended May 7. Closing was expected in Q3 2021, subject to customary conditions; this was an expectation, not a completed transaction.
- PIPE investors agreed to purchase 46.7 million shares at $10 per share for $467 million gross proceeds, contingent on closing.
- The merger agreement describes a $4.0 billion equity-value calculation, subject to a deduction for management redemptions of up to $40 million. Rocket Lab stockholders could receive additional shares if the post-closing stock meets the specified $20 trading-price condition.
- Public shareholders could redeem shares in connection with the combination. Vector’s deadline to complete a business combination was September 29, 2022; otherwise public shares would be redeemed from the trust, while warrants could expire worthless.
- Warrant accounting was a material unusual item: following SEC staff guidance, warrants were classified as liabilities and remeasured at fair value through earnings. Vector identified a material weakness in internal control over financial reporting tied to the prior warrant accounting, concluded disclosure controls were ineffective as of March 31, and described remediation efforts. Management noted potential litigation risk, though it knew of no such litigation at the filing date.
- Vector reported no long-term debt and no off-balance-sheet arrangements. COVID-19 could adversely affect its financial position or target search, but the impact was not then determinable.
Important facts for investors to verify
- Confirm the issuer: this filing reports Vector SPAC results, not Rocket Lab’s standalone operating revenue, margins, cash flow, or debt.
- Check subsequent filings for whether the merger and $467 million PIPE closed, actual redemptions, and final transaction terms.
- Review Rocket Lab’s own filings for operating performance, liquidity, debt, guidance, and business risks.
- Track warrant fair-value changes and remediation of the disclosed material weakness; reported SPAC earnings may fluctuate substantially without corresponding cash flows.